• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . Estimating the burden of influenza-related and associated hospitalizations and deaths in France: An eight-season da

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2022 Jan 10.
doi: 10.1111/irv.12962. Online ahead of print.
Estimating the burden of influenza-related and associated hospitalizations and deaths in France: An eight-season data study, 2010-2018


Magali Lemaitre[SUP] 1 [/SUP], Fayssoil Fouad[SUP] 1 [/SUP], Fabrice Carrat[SUP] 2 3 [/SUP], Pascal Crépey[SUP] 4 [/SUP], Jacques Gaillat[SUP] 5 [/SUP], Gaëtan Gavazzi[SUP] 6 [/SUP], Odile Launay[SUP] 7 8 [/SUP], Anne Mosnier[SUP] 9 [/SUP], Marie-Cécile Levant[SUP] 10 [/SUP], Mathieu Uhart[SUP] 10 [/SUP]



Affiliations

Abstract

Background: In France, each year, influenza viruses are responsible for seasonal epidemics leading to 2-6 million cases. Influenza can cause severe disease that may lead to hospitalization or death. As severe disease may be due to the virus itself or to disease complications, estimating the burden of severe influenza is complex. The present study aimed at estimating the epidemiological and economic burden of severe influenza in France during eight consecutive influenza seasons (2010-2018).
Methods: Influenza-related hospitalization and mortality data and patient characteristics were taken from the French hospital information database, PMSI. An ecological approach using cyclic regression models integrating the incidence of influenza syndrome from the Sentinelles network supplemented the PMSI data analysis in estimating excess hospitalization and mortality (CépiDc-2010-2015) and medical costs.
Results: Each season, the average number of influenza-related hospitalizations was 18,979 (range: 8627-44,024), with an average length of stay of 8 days. The average number of respiratory hospitalizations indirectly related with influenza (i.e., influenza associated) was 31,490 (95% confidence interval [CI]: 24,542-39,012), with an average cost of €141 million (range: 54-217); 70% of these hospitalizations and 77% of their costs concerned individuals ≥65 years of age (65+). More than 90% of excess mortality was in 65+ subjects.
Conclusions: The combination of two complementary approaches allowed estimation of both influenza-related and associated hospitalizations and deaths and their burden in France, showing the substantial impact of complications. The present study highlighted the major public health burden of influenza and its severe complications, especially in 65+ subjects.

Keywords: France; cost of illness; epidemiology; hospitalization; human; mortality.
 
Back
Top Bottom